+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ibandronate: is there an effect on nonvertebral fractures?

Ibandronate: is there an effect on nonvertebral fractures?

Clinical Rheumatology 27(10): 1313-1315

Although ibandronate improves suboptimal compliance in patients receiving weekly bisphosphonates, there is a concern about its effect on the reduction of nonvertebral fractures. In the era of evidence-based medicine, randomized clinical trials are considered the highest quality evidence which guide us to the best clinical decision. Nevertheless, if level 1 evidence is not available, as is the case with ibandronate, evidences of lower levels could be used to draw relevant clinical decision. In this article, we discussed data from clinical trials (subgroup analyses of high-risk patients, meta-analysis of clinical trials) which suggested significant effect of ibandronate on the risk reduction of nonvertebral fractures.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 053653038

Download citation: RISBibTeXText

PMID: 18651099

DOI: 10.1007/s10067-008-0971-4

Related references

Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data. Osteoporosis International 20(2): 291-297, 2009

The Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) study: 2-year nonvertebral fragility fracture results. Osteoporosis International 24(8): 2309-2317, 2013

Ibandronate: a review of its vertebral and nonvertebral antifracture efficacy. Women's Health 5(5): 467-473, 2009

Ibandronate and nonvertebral fracture efficacy: results of a recent pooled analysis. Physician and Sportsmedicine 38(2): 183-185, 2010

Clinical and nonvertebral fracture risk is reduced with the use of ibandronate in women with postmenopausal osteoporosis. 2007

Evidence of sustained vertebral and nonvertebral antifracture efficacy with ibandronate therapy: a systematic review. Therapeutic Advances in Musculoskeletal Disease 3(2): 67-79, 2011

Bone strength measured by peripheral quantitative computed tomography and the risk of nonvertebral fractures: the osteoporotic fractures in men (MrOS) study. Journal of Bone and Mineral Research 26(1): 63-71, 2011

Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study. Osteoporosis International 27(3): 1191-1198, 2016

Effects of raloxifene on vertebral and nonvertebral fractures in postmenopausal women with osteoporosis with multiple prevalent vertebral fractures. Calcified Tissue International 72(4): 391, 2003

Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone 33(4): 522-532, 2003

Albuminuria and risk of nonvertebral fractures. Archives of Internal Medicine 167(13): 1379-1385, 2007

Efficacy of teriparatide and alendronate on nonvertebral fractures. Journal of Clinical Endocrinology and Metabolism 88(3): 1402-3; Author Reply 1403, 2003

The definition and clinical significance of nonvertebral fractures. Current Osteoporosis Reports 8(4): 227-234, 2010

Meta-analysis of prevention of nonvertebral fractures by alendronate. JAMA 278(8): 631; Author Reply 631, 1997

The impact of nonhip nonvertebral fractures in elderly women and men. Journal of Clinical Endocrinology and Metabolism 99(2): 415-423, 2014